These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 22993956)

  • 41. Extrahepatic manifestations in chronic hepatitis C virus carriers.
    Rosenthal E; Cacoub P
    Lupus; 2015 Apr; 24(4-5):469-82. PubMed ID: 25801890
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hepatitis C virus-associated cryoglobulinemic vasculitis: A 20-year experience with treatment].
    Ignatova TM; Kozlovskaya LV; Gordovskaya NB; Chernova OA; Milovanova SY; Novikov PI; Nekrasova TP; Beketova TV; Mukhin NA
    Ter Arkh; 2017; 89(5):46-52. PubMed ID: 28631698
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cryoglobulinemia vasculitis: an update.
    Terrier B; Cacoub P
    Curr Opin Rheumatol; 2013 Jan; 25(1):10-8. PubMed ID: 23196322
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of free light chains in HCV-positive patients with mixed cryoglobulinaemia vasculitis undergoing rituximab treatment.
    Basile U; Gragnani L; Piluso A; Gulli F; Urraro T; Dell'Abate MT; Torti E; Stasi C; Monti M; Rapaccini GL; Zignego AL
    Liver Int; 2015 Sep; 35(9):2100-7. PubMed ID: 25800731
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recovery of hepatitis C specific T-cell responses after rituximab therapy in hepatitis C mixed cryoglobulinemic vasculitis.
    Mathur P; Emmanuel B; Sneller M; Zhang X; Poonia B; Kottilil S
    J Med Virol; 2018 May; 90(5):936-941. PubMed ID: 29236302
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cryoglobulinaemia vasculitis in patients coinfected with HIV and hepatitis C virus.
    Saadoun D; Aaron L; Resche-Rigon M; Pialoux G; Piette JC; Cacoub P;
    AIDS; 2006 Apr; 20(6):871-7. PubMed ID: 16549971
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictors of long-term cryoglobulinemic vasculitis outcomes after HCV eradication with direct-acting antivirals in the real-life.
    Gragnani L; Lorini S; Marri S; Vacchi C; Madia F; Monti M; Ferri C; Zignego AL
    Autoimmun Rev; 2022 Jan; 21(1):102923. PubMed ID: 34419670
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Steroids, interferon-alpha and ribavirin treatment of cryoglobulinemic glomerulonephritis concurrent with HCV infection].
    Guarnieri A; Marazzi F; Giorgi MP; Canepari G; Pino C; Moggia E; Manca A; Ghezzi PM
    G Ital Nefrol; 2002; 19(1):79-81. PubMed ID: 12165950
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cryoglobulinemic vasculitis with primary Sjögren's syndrome: A case report.
    Hasegawa J; Hayami N; Hoshino J; Suwabe T; Sumida K; Mise K; Ueno T; Yamanouchi M; Sawa N; Ohashi K; Fujii T; Takaichi K; Ubara Y
    Mod Rheumatol; 2018 May; 28(3):570-574. PubMed ID: 26743943
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatitis C virus infection, type III cryoglobulinemia, and necrotizing vasculitis.
    Brownell I; Fangman W
    Dermatol Online J; 2007 Jan; 13(1):6. PubMed ID: 17511939
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Health-related quality of life in severe cryoglobulinaemic vasculitis and improvement after B-cell depleting therapy.
    Quartuccio L; Isola M; Masolini P; Scaini P; Zani R; Tavoni A; Pietrogrande M; Bombardieri S; De Vita S
    Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S9-14. PubMed ID: 23044040
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Successful treatment with bortezomib in type-1 cryoglobulinemic vasculitis patient after rituximab failure: a case report and literature review.
    Besada E; Vik A; Koldingsnes W; Nossent JC
    Int J Hematol; 2013 Jun; 97(6):800-3. PubMed ID: 23616220
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Remission of refractory hepatitis C-negative cryoglobulinaemic vasculitis after rituximab and infliximab.
    Koukoulaki M; Abeygunasekara SC; Smith KG; Jayne DR
    Nephrol Dial Transplant; 2005 Jan; 20(1):213-6. PubMed ID: 15632353
    [No Abstract]   [Full Text] [Related]  

  • 54. Life-threatening hepatitis C virus-associated polyarteritis nodosa successfully treated by rituximab.
    Néel A; Masseau A; Hervier B; Bossard C; Cacoub P; Pagnoux C; Hamidou MA
    J Clin Rheumatol; 2011 Dec; 17(8):439-41. PubMed ID: 22089995
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rituximab may form a complex with IgMkappa mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus-induced vasculitis.
    Sène D; Ghillani-Dalbin P; Amoura Z; Musset L; Cacoub P
    Arthritis Rheum; 2009 Dec; 60(12):3848-55. PubMed ID: 19950292
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The expanding spectrum of HCV-related cryoglobulinemic vasculitis: a narrative review.
    Dammacco F; Racanelli V; Russi S; Sansonno D
    Clin Exp Med; 2016 Aug; 16(3):233-42. PubMed ID: 26935415
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vasculitic multiplex mononeuritis: polyarteritis nodosa versus cryoglobulinemic vasculitis.
    Steidl C; Baumgaertel MW; Neuen-Jacob E; Berlit P
    Rheumatol Int; 2012 Aug; 32(8):2543-6. PubMed ID: 20401485
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatitis C virus- related cryoglobulinemic vasculitis: A review of the role of the new direct antiviral agents (DAAs) therapy.
    Mazzaro C; Dal Maso L; Mauro E; Visentini M; Tonizzo M; Gattei V; Andreone P; Pozzato G
    Autoimmun Rev; 2020 Aug; 19(8):102589. PubMed ID: 32540448
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Cutaneous vasculitis with mixed cryoglobulinemia during chronic hepatitis C].
    Rémond B; Reygagne P; Aractingi S; Dubertret L
    Ann Dermatol Venereol; 1992; 119(11):827-9. PubMed ID: 1301689
    [No Abstract]   [Full Text] [Related]  

  • 60. Rapid improvement of psychiatric stigmata after IFN-free treatment in HCV patients with and without cryoglobulinemic vasculitis.
    Gragnani L; Lorini S; Martini L; Stasi C; Visentini M; Petraccia L; Marello N; Monti M; Marri S; Madia F; Ricca V; Zignego AL
    Clin Rheumatol; 2022 Jan; 41(1):147-157. PubMed ID: 34409558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.